- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Statutory Instruments
Dangerous Drugs
Made
10th December 2008
Coming into force
26th January 2009
At the Court at Buckingham Palace, the 10th day of December 2008
Present,
The Queen’s Most Excellent Majesty in Council
In accordance with section 2(5) of the Misuse of Drugs Act 1971(1) a draft of this Order has been laid before Parliament after consultation with the Advisory Council on the Misuse of Drugs and approved by a resolution of each House of Parliament.
Accordingly, Her Majesty, in exercise of the powers conferred upon Her by sections 2(2) and 2(4) of that Act, is pleased, by and with the advice of Her Privy Council, to order as follows:
1.—(1) This Order may be cited as the Misuse of Drugs Act 1971 (Amendment) Order 2008 and shall come into force on 26th January 2009.
(2) The Misuse of Drugs Act 1971 (Modification) (No. 2) Order 2003(2) is revoked.
2.—(1) Schedule 2 to the Misuse of Drugs Act 1971 (which specifies the drugs which are subject to control under that Act) is amended as follows.
(2) In Part 2 (Class B drugs)—
(a)in paragraph 1(a), after “Amphetamine” insert—
“Cannabinol
Cannabinol derivatives
Cannabis and cannabis resin”;
(b)after paragraph 2 insert—
“2A. Any ester or ether of cannabinol or of a cannabinol derivative.”; and
(c)in paragraph 3, for “or 2” substitute “, 2 or 2A”.
(3) In Part 3 (Class C drugs) the following words are repealed —
(a)in paragraph 1(a), “Cannabinol”, “Cannabinol derivatives” and “Cannabis and cannabis resin”; and
(b)in paragraph 1(d), “or of cannabinol or a cannabinol derivative”.
Judith Simpson
Clerk of the Privy Council
(This note is not part of the Order)
This Order reclassifies cannabis, cannabis resin, cannabinol and cannabinol derivatives from Class C to Class B drugs for the purposes of control under the Misuse of Drugs Act 1971. In addition, any substance which is an ester or ether of cannabinol or of a cannabinol derivative is reclassified as a Class B drug.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: